Registered as a drug in Russia since 1994 for ischemic stroke and cognitive impairment, its research focuses on BDNF/NGF upregulation, neuroprotection in ischemia models, and attention enhancement
This genetic metabolic block severely impairs the body's ability to produce cellular energy and clear out neurotoxins, directly contributing to the hallmark symptoms of ME/CFS, including profound post-exertional malaise (PEM) and unrefreshing sleep
Drug design, development and therapy , 9 , 24852499
Water fluctuations, muscle changes, and timing of measurements create noise that obscures actual fat loss
Proper handling secures the integrity of the solution throughout the usage period
With regard to duration of AEs, some AEs either diminish over time and/or readily cease upon cessation of the treatment